APA (7th ed.) Citation

Fu, L., Xue, R., Chen, J., Jia, G., Pang, X., & Cui, Y. Comparative Assessment of Pivotal Trials Supporting the Indication Approvals of Innovative and Modified New Anticancer Drugs in China, 2016–2022. American Association for the Advancement of Science (AAAS).

Chicago Style (17th ed.) Citation

Fu, Lixia, Ruifen Xue, Jie Chen, Guoshu Jia, Xiaocong Pang, and Yimin Cui. Comparative Assessment of Pivotal Trials Supporting the Indication Approvals of Innovative and Modified New Anticancer Drugs in China, 2016–2022. American Association for the Advancement of Science (AAAS).

MLA (9th ed.) Citation

Fu, Lixia, et al. Comparative Assessment of Pivotal Trials Supporting the Indication Approvals of Innovative and Modified New Anticancer Drugs in China, 2016–2022. American Association for the Advancement of Science (AAAS).